Testing a glucose sensor worn by young people with obesity
Tests whether continuous glucose monitors can be used by children and teens with obesity.
Key facts
- Who runs it
- University of California, Los Angeles
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 17 Jan 2023
- Planned end
- Jun 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Continuous glucose monitor
- Record updated
- 12 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children, teenagers and young adults aged 10 to 21 with obesity. It studies whether continuous glucose monitors can be used by them.
- Age
- 10 to 21 years
- Sex
- All sexes can join.
- Disease stage
- BMI above the 95th percentile.
- Earlier treatment
- People currently taking medication that affects weight cannot join. People who have had or are planning weight-loss (bariatric) surgery cannot join.
- Biomarker or test result
- Hemoglobin A1c must not be above 6.5 % (48 mmol/mol).
Main reasons for not taking part
- Prader Willi Syndrome or hypothalamic obesity
- Intellectual disability
- Previous or planned bariatric surgery
- Hemoglobin A1c above 6.5 % (48 mmol/mol)
- Current use of medication that impacts weight
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age 10-21 years BMI >95th percentile
Who cannot take part
- Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
- Previous or planned bariatric surgery
- Current use of medication that impacts weight
- Hemoglobin A1c >6.5 %
- Intellectual disability
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 21 years old?
Where in United States
- Pediatric Endocrinology Division, University of CaliforniaLos Angeles, United StatesContact: Sri Nikhita ChimatapuTaking people
About the trial
What the trial wants to find out
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
The 2 groups in the trial
- UnblindedTreatment being tested
They will wear the device and have access to their data- UNBLINDED ARM
Treatment: Continuous glucose monitor
- BlindedTreatment being tested
They will wear the device but will not have access to their data- BLINDED ARM
Treatment: Continuous glucose monitor
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
- Plain-language title
- Testing a glucose sensor worn by young people with obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06254768, who can take part
- Record updated
- 12 February 2024